Cite Filings / INO / 0001172661-25-004827
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

INOVIO PHARMACEUTICALS, INC. · Filed 2025-11-14 · Acc 0001172661-25-004827

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-12-08 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-11-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-11-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-11-13 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-11-12 8-K Material agreement · Other events
  • 2025-07-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · TANG CAPITAL MANAGEMENT, LLC 9.99%
  2. 2026-11-16 SCHEDULE 13G/A · Alyeska Investment Group, L.P. 3.32%
  3. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 7.4%
  4. 2026-11-16 SCHEDULE 13G/A · Highbridge Capital Management, LLC 9.9%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…